These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 22675662)
1. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Spudich S; González-Scarano F Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007120. PubMed ID: 22675662 [TBL] [Abstract][Full Text] [Related]
2. HIV pharmacology: barriers to the eradication of HIV from the CNS. McGee B; Smith N; Aweeka F HIV Clin Trials; 2006; 7(3):142-53. PubMed ID: 16880170 [TBL] [Abstract][Full Text] [Related]
3. Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Kranick SM; Nath A Continuum (Minneap Minn); 2012 Dec; 18(6 Infectious Disease):1319-37. PubMed ID: 23221843 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy. Balcom EF; Roda WC; Cohen EA; Li MY; Power C Curr Opin Virol; 2019 Oct; 38():54-62. PubMed ID: 31390580 [TBL] [Abstract][Full Text] [Related]
10. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus. Bogoch II; Davis BT; Venna N J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774 [TBL] [Abstract][Full Text] [Related]
11. Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy. Power C; Gill MJ; Johnson RT Can J Neurol Sci; 2002 Feb; 29(1):19-32. PubMed ID: 11858531 [TBL] [Abstract][Full Text] [Related]
12. Clinical implications of HIV-1 drug resistance in the neurological compartment. Antinori A; Cingolani A; Giancola ML; Forbici F; De Luca A; Perno CF Scand J Infect Dis Suppl; 2003; 106():41-4. PubMed ID: 15000582 [TBL] [Abstract][Full Text] [Related]
13. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. Chan P; Brew BJ Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139 [TBL] [Abstract][Full Text] [Related]
14. Developments in HIV neuropathogenesis. Rumbaugh JA; Nath A Curr Pharm Des; 2006; 12(9):1023-44. PubMed ID: 16515484 [TBL] [Abstract][Full Text] [Related]
15. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK J Virol; 2004 Sep; 78(18):10133-48. PubMed ID: 15331746 [TBL] [Abstract][Full Text] [Related]
16. Neurologic complications of HIV infection. Spudich SS; Ances BM Top Antivir Med; 2012; 20(2):41-7. PubMed ID: 22710906 [TBL] [Abstract][Full Text] [Related]
17. Viral infections of the central nervous system: pathogenesis to therapeutics. Soldan SS; Jacobson S J Neuroimmune Pharmacol; 2010 Sep; 5(3):267-70. PubMed ID: 20658202 [No Abstract] [Full Text] [Related]
19. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics. Peluso MJ; Spudich S Curr HIV/AIDS Rep; 2014 Sep; 11(3):353-62. PubMed ID: 25063356 [TBL] [Abstract][Full Text] [Related]